Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Breakthrough Genomics, |
RCV000958295 | SCV005238830 | benign | not provided | criteria provided, single submitter | not provided | ||
| Fulgent Genetics, |
RCV002492876 | SCV002796806 | likely benign | Medulloblastoma; Pilomatrixoma; Ovarian neoplasm; Severe intellectual disability-progressive spastic diplegia syndrome; Hepatocellular carcinoma; Colorectal cancer; Exudative vitreoretinopathy 7 | 2021-10-26 | criteria provided, single submitter | clinical testing | |
| Ce |
RCV000958295 | SCV002563762 | likely benign | not provided | 2025-06-01 | criteria provided, single submitter | clinical testing | CTNNB1: BP4, BP7, BS2 |
| Gene |
RCV000958295 | SCV001846465 | benign | not provided | 2018-09-07 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000958295 | SCV001105129 | benign | not provided | 2025-01-28 | criteria provided, single submitter | clinical testing | |
| Genetic Services Laboratory, |
RCV000193388 | SCV000247138 | benign | not specified | 2015-11-10 | criteria provided, single submitter | clinical testing |